Kengo Takeuchi

45PUBLICATIONS

220CO-AUTHORS

Oncology and carcinogenesis not elsewhere classifiedTumour immunologyPredictive and prognostic markersGene and molecular therapySolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (45)

Sort by Publication Date:

|May 20, 2026

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

|Mar 31, 2026

Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity.

Nobuhiko Yamauchi, Yuko Mishima, Tomoko Takayama

|Jan 08, 2026

Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.

Manabu Takamatsu, Mariko Tanaka, Yohei Masugi

|Dec 29, 2025

Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in Japan.

Tetsuya Mori, Akiko Kada, Tomoo Osumi

|Dec 15, 2025

The first case of <i>GOLGA5-RET</i> fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.

Takehiro Nakao, Naoki Fukuda, Xiaofei Wang

|Sep 16, 2025

Proliferative osteoid osteoma with COL1A1::USP6 gene fusion.

Masafumi Seki, Kyoko Yamashita, Akito Dobashi

Pageof 8

Frequent Collaborators

Yasunori Kogure

Naoko Tsuyama

Yukiko Sato

Ryohei Katayama

Kentaro Inamura

Yasuyuki Shigematsu

Akito Dobashi

Junji Koya

Seishi Ogawa

Keisuke Kataoka

Frequent Collaborators

Yasunori Kogure

Naoko Tsuyama

Yukiko Sato

Ryohei Katayama